CVS Test 2 February 2015
- 1.This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:Oedema was found to be more likely tooccur in patients who were older andheavier.
- A.
True
- B.
False
- 2.This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:An analysis of the United KingdomProspective Diabetes Study showedthat, in the long term, monotherapy withmetformin is more effective in achievingglycaemic targets in overweight patientsthan sulfonylureas.
- A.
True
- B.
False
- 3.This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:Gliclazide modified release has beenshown to assist obese patients in avoidingfurther weight gain during treatment
- A.
True
- B.
False
- 4.This question refer to the article “Areview of perindopril arginine and itsbenefits”:Perindoprilat is a metabolite ofperindopril.
- A.
True
- B.
False
- 5.This question refer to the article “Areview of perindopril arginine and itsbenefits”:Perindopril arginine has an increasedshelf life compared to perindopril tertbutylamineand is suitable for use inclimatic zones III and IV
- A.
True
- B.
False
- 6.This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:Hypertension and dyslipidaemiaare implicated as risk factors fordiabetic microangiopathy only, whilemacroangiopathy is not affected.
- A.
True
- B.
False
- 7.This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:Compliance and glycaemic control in type2 diabetic patients has been shown toimprove with which of the following?
- A.
Twice daily dosing
- B.
A high daily dose frequency
- C.
Once daily dosing
- D.
None of the above
- 8.This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:Good glycaemic control can assist withwhich of the following? Choose all thatapply.[you must choose all the right ones to get a full mark]
- A.
Primary prevention of microvascular complications
- B.
Primary prevention of macrovascular complications
- C.
Secondary prevention of microvascular complications
- D.
Secondary prevention of macrovascular complicatIons
- 9.This question refer to the article “Areview of perindopril arginine and itsbenefits”:Which one of the following is not anindication of perindopril?
- A.
Treatment of symptomatic heart failure
- B.
Reduction of cardiac risk in patients with a history of myocardial infarction (MI) and/or coronary revascularisation
- C.
Treatment of essential hypertension
- D.
Treatment of unstable angina
- 10.This question refer to the article “Areview of perindopril arginine and itsbenefits”:Bioequivalence of the perindopril arginineand tert-butylamine salts has beendemonstrated with an area under theplasma concentration-time curve (AUCt)ratio of …
- A.
93,6 % for perindopril
- B.
100,0 % for perindoprilat
- C.
98,2 % for perindopril
- D.
None of the above
- 11.This question refer to the article “Areview of perindopril arginine and itsbenefits”:Perindopril arginine and perindopril-tertbutylaminecan be considered equivalentand interchangable.
- A.
True
- B.
False
- 12.This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:The main steps in the mechanismsregulating blood pressure (BP) arecircadian-stage-dependent.
- A.
True
- B.
False
- 13.This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:The patients in the trial were given a doseof nifedipine of:
- A.
20 mg/day
- B.
30 mg/day
- C.
60 mg/day
- D.
None of the above
- 14.This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:After 8 weeks of treatment the proportionof patients with a nondipper BP pattern:
- A.
Decreased in the group given nifedipine on awakening
- B.
Increased in the group given nifedipine on awakening
- C.
Increased in the group given nifedipine at bedtime
- D.
Decreased in the group given nifedipine at bedtime
- 15.This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:Night time dosing of nifedipine was shownto reduce the total incidence of oedemafrom:
- A.
13,4 % to 1,0 %
- B.
17,5 % to 4,0 %
- C.
13,5 % to 4,0 %
- D.
17,4 % to 1,0 %
Related Topics
Back to top